Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...

Many patients with heart dysfunction have pulmonary hypertension, more so if they have enlarged hearts or irregular ...

Foresee Pharma begins patient dosing in phase 2 WINDWARD study of mirivadelgat to treat pulmonary hypertension-associated interstitial lung disease: Taipei, Taiwan Friday, May 16, ...

Since many of the observed benefits of PDE5 inhibition with regard to left ventricular hypertrophy, ventricular-vascular stiffening, renal dysfunction, and pulmonary hypertension may be ...

The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no ...

Data demonstrates CorVista’s proprietary machine-learned algorithm detects elevated mean pulmonary artery pressure (mPAP) ...

A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

The benefits were seen across components of that primary endpoint ... clinical worsening events for people with WHO group 1 pulmonary hypertension. These "dramatic" benefits in ZENITH provide ...

The Chronic Thromboembolic Pulmonary Hypertension (CTEPH) program at Baylor St. Luke’s Medical Center is one of a handful of specialized programs in the country offering expert multidisciplinary care ...